Brain+ ApS (BRAINP) - Total Liabilities
Based on the latest financial reports, Brain+ ApS (BRAINP) has total liabilities worth Dkr20.90 Million DKK (≈ $3.27 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Brain+ ApS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Brain+ ApS - Total Liabilities Trend (2015–2024)
This chart illustrates how Brain+ ApS's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Brain+ ApS.
Brain+ ApS Competitors by Total Liabilities
The table below lists competitors of Brain+ ApS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DP Poland Plc
LSE:DPP
|
UK | GBX19.33 Million |
|
Norrland Gold Corp
V:NORR
|
Canada | CA$27.84K |
|
National World PLC
LSE:NWOR
|
UK | GBX22.70 Million |
|
James Cropper PLC
LSE:CRPR
|
UK | GBX52.55 Million |
|
Vivanco Gruppe AG
F:VG0K
|
Germany | €23.05 Million |
|
Shanti Overseas (India) Limited
NSE:SHANTI
|
India | Rs142.01 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Brain+ ApS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BRAINP equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Brain+ ApS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Brain+ ApS (2015–2024)
The table below shows the annual total liabilities of Brain+ ApS from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Dkr22.15 Million ≈ $3.47 Million |
-6.08% |
| 2023-12-31 | Dkr23.59 Million ≈ $3.69 Million |
-18.64% |
| 2022-12-31 | Dkr28.99 Million ≈ $4.54 Million |
+10.31% |
| 2021-12-31 | Dkr26.28 Million ≈ $4.11 Million |
-6.05% |
| 2020-12-31 | Dkr27.97 Million ≈ $4.38 Million |
+35.70% |
| 2019-12-31 | Dkr20.61 Million ≈ $3.23 Million |
+24.67% |
| 2018-12-31 | Dkr16.53 Million ≈ $2.59 Million |
+73.13% |
| 2017-12-31 | Dkr9.55 Million ≈ $1.49 Million |
+88.51% |
| 2016-12-31 | Dkr5.07 Million ≈ $792.61K |
+91.33% |
| 2015-12-31 | Dkr2.65 Million ≈ $414.27K |
-- |
About Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more